TY - JOUR
T1 - A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT
AU - Hong, Cheng William
AU - Chernyak, Victoria
AU - Choi, Jin Young
AU - Lee, Sonia
AU - Potu, Chetan
AU - Delgado, Timoteo
AU - Wolfson, Tanya
AU - Gamst, Anthony
AU - Birnbaum, Jason
AU - Kampalath, Rony
AU - Lall, Chandana
AU - Lee, James T.
AU - Owen, Joseph W.
AU - Aguirre, Diego A.
AU - Mendiratta-Lala, Mishal
AU - Davenport, Matthew S.
AU - Masch, William
AU - Roudenko, Alexandra
AU - Lewis, Sara C.
AU - Kierans, Andrea Siobhan
AU - Hecht, Elizabeth M.
AU - Bashir, Mustafa R.
AU - Brancatelli, Giuseppe
AU - Douek, Michael L.
AU - Ohliger, Michael A.
AU - Tang, An
AU - Cerny, Milena
AU - Fung, Alice
AU - Costa, Eduardo A.
AU - Corwin, Michael T.
AU - McGahan, John P.
AU - Kalb, Bobby
AU - Elsayes, Khaled M.
AU - Surabhi, Venkateswar R.
AU - Blair, Katherine
AU - Marks, Robert M.
AU - Horvat, Natally
AU - Best, Shaun
AU - Ash, Ryan
AU - Ganesan, Karthik
AU - Kagay, Christopher R.
AU - Kambadakone, Avinash
AU - Wang, Jin
AU - Cruite, Irene
AU - Bijan, Bijan
AU - Goodwin, Mark
AU - Cunha, Guilherme Moura
AU - Tamayo-Murillo, Dorathy
AU - Fowler, Kathryn J.
AU - Sirlin, Claude B.
N1 - Publisher Copyright:
© RSNA, 2023.
PY - 2023/6
Y1 - 2023/6
N2 - Background: Various limitations have impacted research evaluating reader agreement for Liver Imaging Reporting and Data System (LI-RADS). Purpose: To assess reader agreement of LI-RADS in an international multicenter multireader setting using scrollable images. Materials and Methods: This retrospective study used deidentified clinical multiphase CT and MRI and reports with at least one untreated observation from six institutions and three countries; only qualifying examinations were submitted. Examination dates were October 2017 to August 2018 at the coordinating center. One untreated observation per examination was randomly selected using observation identifiers, and its clinically assigned features were extracted from the report. The corresponding LI-RADS version 2018 category was computed as a rescored clinical read. Each examination was randomly assigned to two of 43 research readers who independently scored the observation. Agreement for an ordinal modified four-category LI-RADS scale (LR-1, definitely benign; LR-2, probably benign; LR-3, intermediate probability of malignancy; LR-4, probably hepatocellular carcinoma [HCC]; LR-5, definitely HCC; LR-M, probably malignant but not HCC specific; and LR-TIV, tumor in vein) was computed using intraclass correlation coefficients (ICCs). Agreement was also computed for dichotomized malignancy (LR-4, LR-5, LR-M, and LR-TIV), LR-5, and LR-M. Agreement was compared between research-versus-research reads and research-versus-clinical reads. Results: The study population consisted of 484 patients (mean age, 62 years ± 10 [SD]; 156 women; 93 CT examinations, 391 MRI examinations). ICCs for ordinal LI-RADS, dichotomized malignancy, LR-5, and LR-M were 0.68 (95% CI: 0.61, 0.73), 0.63 (95% CI: 0.55, 0.70), 0.58 (95% CI: 0.50, 0.66), and 0.46 (95% CI: 0.31, 0.61) respectively. Research-versus-research reader agreement was higher than research-versus-clinical agreement for modified four-category LI-RADS (ICC, 0.68 vs 0.62, respectively; P = .03) and for dichotomized malignancy (ICC, 0.63 vs 0.53, respectively; P = .005), but not for LR-5 (P = .14) or LR-M (P = .94). Conclusion: There was moderate agreement for LI-RADS version 2018 overall. For some comparisons, research-versus-research reader agreement was higher than research-versus-clinical reader agreement, indicating differences between the clinical and research environments that warrant further study.
AB - Background: Various limitations have impacted research evaluating reader agreement for Liver Imaging Reporting and Data System (LI-RADS). Purpose: To assess reader agreement of LI-RADS in an international multicenter multireader setting using scrollable images. Materials and Methods: This retrospective study used deidentified clinical multiphase CT and MRI and reports with at least one untreated observation from six institutions and three countries; only qualifying examinations were submitted. Examination dates were October 2017 to August 2018 at the coordinating center. One untreated observation per examination was randomly selected using observation identifiers, and its clinically assigned features were extracted from the report. The corresponding LI-RADS version 2018 category was computed as a rescored clinical read. Each examination was randomly assigned to two of 43 research readers who independently scored the observation. Agreement for an ordinal modified four-category LI-RADS scale (LR-1, definitely benign; LR-2, probably benign; LR-3, intermediate probability of malignancy; LR-4, probably hepatocellular carcinoma [HCC]; LR-5, definitely HCC; LR-M, probably malignant but not HCC specific; and LR-TIV, tumor in vein) was computed using intraclass correlation coefficients (ICCs). Agreement was also computed for dichotomized malignancy (LR-4, LR-5, LR-M, and LR-TIV), LR-5, and LR-M. Agreement was compared between research-versus-research reads and research-versus-clinical reads. Results: The study population consisted of 484 patients (mean age, 62 years ± 10 [SD]; 156 women; 93 CT examinations, 391 MRI examinations). ICCs for ordinal LI-RADS, dichotomized malignancy, LR-5, and LR-M were 0.68 (95% CI: 0.61, 0.73), 0.63 (95% CI: 0.55, 0.70), 0.58 (95% CI: 0.50, 0.66), and 0.46 (95% CI: 0.31, 0.61) respectively. Research-versus-research reader agreement was higher than research-versus-clinical agreement for modified four-category LI-RADS (ICC, 0.68 vs 0.62, respectively; P = .03) and for dichotomized malignancy (ICC, 0.63 vs 0.53, respectively; P = .005), but not for LR-5 (P = .14) or LR-M (P = .94). Conclusion: There was moderate agreement for LI-RADS version 2018 overall. For some comparisons, research-versus-research reader agreement was higher than research-versus-clinical reader agreement, indicating differences between the clinical and research environments that warrant further study.
UR - http://www.scopus.com/inward/record.url?scp=85166215981&partnerID=8YFLogxK
U2 - 10.1148/radiol.222855
DO - 10.1148/radiol.222855
M3 - Article
C2 - 37489994
AN - SCOPUS:85166215981
SN - 0033-8419
VL - 307
JO - Radiology
JF - Radiology
IS - 5
M1 - e222855
ER -